DeutschNewstral
Article
Mmarketwatch.com on 2018-02-08 13:23
Teva shares plummet 10% after downbeat 2018 guidance
Related news
- MTeva shares surge 6.5% on Q1 beats, higher 2018 guidancemarketwatch.com
- MValeant shares drop 3.5% after Q4 revenue miss, downbeat 2018 guidancemarketwatch.com
- MFlexion shares plummet after weak revenue guidancemarketwatch.com
- MTeva stock surges 6% on Q3 beats, upbeat guidancemarketwatch.com
- MFoot Locker shares plummet after lackluster second-quarter guidancemarketwatch.com
- MMacy's shares plummet 12% after earnings miss, weak guidancemarketwatch.com
- MCarrols Restaurant shares plummet after earnings miss, weak guidancemarketwatch.com
- MNu Skin shares plummet, stock downgraded after guidance slashedmarketwatch.com
- MTeva shares rise 9%marketwatch.com
- MUnited shares higher on earnings beat, upped 2018 guidancemarketwatch.com
- MCVS shares rise after profit beat, upbeat 2018 guidancemarketwatch.com
TASE: Teva shares down 8.6%israelnationalnews.com- Teva shares fall by 15%israelnationalnews.com
- MTeva shares rise as company offers reassurance on former flagship drug Copaxonemarketwatch.com
- M3M stock drops 7.5% after Q3 misses, downbeat guidancemarketwatch.com
- MMichaels's stock plunges after profit and sales miss, downbeat guidancemarketwatch.com
Teva buying up shares of Mylanbizjournals.com- MTeva shares rise on debt covenant amendmentsmarketwatch.com
- BTeva Pharmaceutical’s Prospects Are Improving, Analyst Says. He’s Downbeat on a Rival.barrons.com
- Box shares plummet on weak earnings, guidancebizjournals.com